Tender Offers for ALX ONCOLOGY HOLDINGS INC

Form Type: SC TO-I/A

Filing Date: 2024-12-31

Corporate Action: Tender-offer

Type: Update

Accession Number: 000119312524287178

Comments: This Amendment No. 1 to the Tender Offer Statement on Schedule TO modifies the previously filed documents related to ALX Oncology Holdings Inc.'s tender offer to exchange certain options for new options. The tender offer, which commenced on December 2, 2024, expired at 9:00 p.m. PT on December 30, 2024. As a result of the offer, 64 eligible employees tendered options to purchase a total of 2,693,873 shares of common stock, which represents approximately 80.3% of the total shares underlying the eligible options. All surrendered options were canceled the same day as the expiration of the offer, and new options were granted for a total of 2,155,095 shares. This amendment specifically updates Item 4 of the original filing to reflect the final results of the offer, while other parts of the Schedule TO remain unchanged.

Document Link: View Document